Hoppa till huvudinnehåll
For Healthcare
Professionals
Therapeutic areas
Products
Tools
Contact
Therapeutic areas
Haematology
Immunology
Products
Doptelet
Elocta
Kineret
Aspaveli
Tools
Contact
Primära flikar
Logga in
Skapa nytt konto
Återställ ditt lösenord
Logga in
Login by username/email address *
You can use your username or email address to login.
Lösenord *
Registrera nytt konto
Jag har glömt mitt lösenord
Therapeutic areas
Haematology
Immune thrombocytopenia (ITP)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Immunology
Interleukin-1 and autoinflammatory diseases
Products
Doptelet
Introduction to ITP
About ITP
Challenge expectations in ITP
Today’s expectations
Challenge expectations
Efficacy
Durable response within 8 days
Consistent response
Effect and durable response
Dosing
Safety profile
Guidelines
Prescribing information
Elocta
About haemophilia A
The impact of haemophilia
Is FVIII still fundamental?
Personalised protection
Indications for ELOCTA
Mechanism of action
Personalised prophylaxis
Efficacy
Robust trial programme
Bleed protection
Safety profile
Safety profile
Additional information
Administration
Resources
Prescribing information
Kineret
This is how Kineret works
Resources
Prescribing information
Aspaveli
About PNH
Patient Burden
Ongoing anaemia
Mechanism of action
Efficacy
Clinical Efficacy
Patient outcomes
Safety
Safety Profile
Before Prescribing
Administration
Self-administration
Starting Aspaveli
Resources
Prescribing information
Tools
Contact
Logga in
Other sites
expand_less
